Angiogenesis factor in endometrial carcinoma: A new prognostic indicator?
- 30 June 1996
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 174 (6) , 1879-1884
- https://doi.org/10.1016/s0002-9378(96)70224-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- HER-2/neu, P53, and DNA analyses as prognosticators for survival in endometrial carcinomaPublished by Wolters Kluwer Health ,2002
- Angiogenesis in Endometrial Hyperplasia and Stage I Endometrial CarcinomaPublished by Wolters Kluwer Health ,1995
- Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast CarcinomaJNCI Journal of the National Cancer Institute, 1992
- Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by human endometrial cancerAmerican Journal of Obstetrics and Gynecology, 1992
- Relation of neovascularisation to metastasis of non-small-cell lung cancerThe Lancet, 1992
- Biology of tumour metastasisThe Lancet, 1992
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group studyGynecologic Oncology, 1991
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971